Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Body Mass Index
100%
Intermediate Grade
100%
B-cell non-Hodgkin Lymphoma (B-NHL)
100%
Patients Receiving Chemotherapy
100%
Obesity
66%
B-cell NHL
66%
Risk Factors
33%
Prognostic Factors
33%
Improved Survival
33%
Treatment Outcome
33%
Patient Demographics
33%
World Health Organization
33%
Treatment Survival
33%
Demographic Variables
33%
Increasing Prevalence
33%
Frontline Therapy
33%
Treatment-naïve
33%
Treatment Variable
33%
Cox Proportional Hazards Regression
33%
Retrospective Cohort Study
33%
Adiposity
33%
Regression Modeling
33%
Online Treatment
33%
Treatment Intensity
33%
Disease Variables
33%
Increased BMI
33%
Patient Treatment
33%
Nursing and Health Professions
Body Mass
100%
Chemotherapy
100%
Nonhodgkin Lymphoma
100%
Obesity
100%
Diseases
50%
Treatment Outcome
50%
Prevalence
50%
Proportional Hazards Model
50%
World Health Organization
50%
Cohort Analysis
50%
Medicine and Dentistry
Body Mass Index
100%
Chemotherapy
100%
Non-Hodgkin Lymphoma
100%
B Cell
100%
Obesity
33%
Diseases
16%
Prevalence
16%
Prognostic Factor
16%
Proportional Hazards Model
16%
Retrospective Cohort Study
16%
Treatment Outcome
16%
Median Follow Up
16%
Immunology and Microbiology
B Cell
100%
Body Mass
100%
Prevalence
33%